What is the current market size and future outlook for the boronate affinity tests market?
The boronate affinity tests market size has grown rapidly in recent years. It will grow from $3.47 billion in 2024 to $3.82 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to increased research and development, a rising incidence of chronic diseases, a growing biotechnology industry, growing government and academic research funding, increasing demand for personalized medicine, and increased availability of advanced equipment.
The boronate affinity tests market size is expected to see strong growth in the next few years. It will grow to $5.58 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to growing adoption in clinical diagnostics, rising awareness and education, expansion into emerging markets, strategic collaborations and partnerships, increasing prevalence of metabolic disorders, and a growing focus on early disease detection. Major trends in the forecast period include integration with digital health, automation and high-throughput screening, expansion in clinical applications, advancements in sample preparation, an increased focus on glycomics, the development of new reagents and kits, and regulatory advancements.
Get Your Free Sample of The Global Boronate Affinity Tests Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18266&type=smp
How has the boronate affinity tests market evolved, and what factors have shaped its growth?
The increasing diabetic population is expected to propel the growth of the boronate affinity tests market going forward. Diabetes is a chronic medical condition characterized by high blood glucose levels due to the body’s inability to produce or effectively use insulin. The diabetes cases are rising due to poor diet, especially high consumption of processed foods and sugary drinks, and sedentary lifestyles characterized by minimal physical activity. Moreover, the aging population and family history of diabetes increase the risk, indicating a genetic predisposition. Boronate affinity tests are used in diabetes management to accurately measure glycated proteins, providing a reliable indicator of long-term blood glucose control. For instance, in June 2023, according to the data published by The Lancet, a UK-based book and periodic data publishing organization, global diabetes cases are projected to increase from 529 million in 2021 to 1.3 billion by 2050. Therefore, the increasing diabetic population will drive the growth of the boronate affinity tests market.
What are the major segments of the boronate affinity tests market?
The boronate affinity tests market covered in this report is segmented –
1) By Product Type: Test Kits, Instruments, Consumables
2) By Technology: Fluorescence Based Tests, Colorimetric Assays, Electrochemical Methods
3) By Indication: Type 1 Diabetes, Type 2 Diabetes
4) By End User: Hospitals And Clinics, Diagnostics Laboratories, Research Institutes, Pharmaceutical And Biotechnology Companies
Subsegments:
1) By Test Kits: Boronate Affinity Glycoprotein Test Kits, Boronate Affinity Drug Detection Test Kits, Boronate Affinity Biomarker Test Kits
2) By Instruments: Boronate Affinity Chromatography Systems, Spectrometers For Boronate Affinity Analysis, Automated Boronate Affinity Test Analyzers
3) By Consumables: Boronate Affinity Resin Columns, Boronate Affinity Membranes
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/boronate-affinity-tests-global-market-report
Which companies dominate the boronate affinity tests market?
Major companies operating in the boronate affinity tests market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Merck KGaA, Tosoh Corporation, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Alere Inc, Green Cross Holdings Corp., Bio-Techne Corporation, ARKRAY Inc, EKF Diagnostics Holdings plc, HemoCue AB, Trinity Biotech, SeraCare Life Sciences Inc, Medix Biochemica, PTS Diagnostics, Biosynth, Santa Cruz Biotechnology, A Menarini Diagnostics Srl, Diazyme Laboratories Inc, Bioventix PLC, GenWay Biotech Inc, Diatheva, OSANG Healthcare Co Ltd, Cypress Diagnostics, Goldsite Diagnostics Inc
What are the key regional dynamics of the boronate affinity tests market, and which region leads in market share?
North America was the largest region in the boronate affinity tests market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the boronate affinity tests market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Boronate Affinity Tests Market Report 2025 Offer?
The boronate affinity tests market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Boronate affinity tests are used to study the interactions between boron-containing compounds and molecules with diol or other cis-diol functional groups. These tests leverage the unique ability of boronate esters to form reversible covalent bonds with diol groups, which is useful for various applications such as protein and carbohydrate analysis and drug development.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18266
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
